EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictive Factors and Clinical Impact of Radioactive Seed Migration After Prostate Brachytherapy: A Retrospective Study

Shota Kikuchi, Takashi Fukagai iD, Jin Yamatoya, Kazuhiko Oshinomi, Masakazu Nagata, Masashi Morita iD, Kosuke Toyofuku, Atsuhito Sekimoto, Masako Kato iD, Madoka Morota, Yoshinori Ito

Current Oncology · 2025

DOI: 10.3390/curroncol32100567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Shota Kikuchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan. Hauptthemen laut MEDLINE: Brachytherapy, Prostatic Neoplasms, Iodine Radioisotopes. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radioactive seed migration after low-dose-rate brachytherapy (LDR-BT) for prostate cancer is a known phenomenon; however, its clinical impact remains unclear. We retrospectively analyzed 611 patients treated with LDR-BT using loose iodine-125 seeds. Post-treatment imaging was used to assess seed migration. Treatment efficacy was evaluated using post-plan dosimetry (V100 and D90) and biochemical recurrence-free survival (bRFS). Seed migration was observed in 150 patients (24.5%) within 1–3 months post-treatment, involving a total of 210 seeds. Migration sites included lungs, vasculature, and seminal vesicles. Hematogenous migration was significantly associated with higher seed counts. Seminal vesicle migration was linked to increased needle usage and absence of neoadjuvant hormone therapy. No significant differences were observed in V100, D90, or bRFS between patients with or without seed migration. However, migration of ≥3 seeds correlated with significantly lower V100 and with a trend toward decreased bRFS. Limited seed migration appears to have minimal clinical impact. However, ≥3 migrated seeds may reduce dosimetric quality and affect treatment efficacy. Risk factors include larger prostate volume as well as higher seed and needle counts. Improved planning and using linked seeds may reduce migration and improve outcomes in LDR-BT for prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyProstatic NeoplasmsIodine RadioisotopesHumansMaleRetrospective StudiesAgedMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

brachytherapypermanent seed implantationprostate cancerradiotherapyseed migration

Substanzen

Iodine RadioisotopesIodine-125

Autor:innen und Institutionen

  • Department of Urology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
  • Division of Radiation Oncology, Department of Radiology, School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.

ORCID-Profile: Takashi Fukagai, Masashi Morita, Masako Kato

Zitieren

APA

Kikuchi, S., Fukagai, T., Yamatoya, J., Oshinomi, K., Nagata, M., Morita, M., Toyofuku, K., Sekimoto, A., Kato, M., Morota, M., & Ito, Y. (2025). Predictive Factors and Clinical Impact of Radioactive Seed Migration After Prostate Brachytherapy: A Retrospective Study. Current Oncology. https://doi.org/10.3390/curroncol32100567

Vancouver

Kikuchi S, Fukagai T, Yamatoya J, Oshinomi K, Nagata M, Morita M, et al. Predictive Factors and Clinical Impact of Radioactive Seed Migration After Prostate Brachytherapy: A Retrospective Study. Current Oncology. 2025. doi:10.3390/curroncol32100567

BibTeX
@article{Kikuchi2025,
  author = {Kikuchi, Shota and Fukagai, Takashi and Yamatoya, Jin and Oshinomi, Kazuhiko and Nagata, Masakazu and Morita, Masashi and Toyofuku, Kosuke and Sekimoto, Atsuhito and Kato, Masako and Morota, Madoka and Ito, Yoshinori},
  title = {Predictive Factors and Clinical Impact of Radioactive Seed Migration After Prostate Brachytherapy: A Retrospective Study},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32100567}
}
Kostenlos starten →